At the time of writing, Merck & Co Inc [MRK] stock is trading at $106.78, up 0.31%. An important factor to consider is whether the stock is rising or falling in short-term value. The MRK shares have gain 6.05% over the last week, with a monthly amount glided 1.06%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Merck & Co Inc [NYSE: MRK] stock has seen the most recent analyst activity on December 18, 2025, when BMO Capital Markets upgraded its rating to an Outperform but kept the price target unchanged to $130 for it. Previously, Wells Fargo upgraded its rating to Overweight on November 24, 2025, and kept the price target unchanged to $125. On November 13, 2025, Scotiabank initiated with a Sector Outperform rating and assigned a price target of $105 on the stock. Berenberg downgraded its rating to a Hold but $90 remained the price target by the analyst firm on September 17, 2025. Citigroup downgraded its rating to Neutral for this stock on May 14, 2025, but kept the price target unchanged to $84. In a note dated April 22, 2025, Cantor Fitzgerald initiated a Neutral rating and provided a target price of $85 on this stock.
For the past year, the stock price of Merck & Co Inc fluctuated between $73.31 and $106.95. Currently, Wall Street analysts expect the stock to reach $114.86 within the next 12 months. Merck & Co Inc [NYSE: MRK] shares were valued at $106.78 at the most recent close of the market. An investor can expect a potential return of 7.57% based on the average MRK price forecast.
Analyzing the MRK fundamentals
According to Merck & Co Inc [NYSE:MRK], the company’s sales were 63.90B for trailing twelve months, which represents an 2.80% jump. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at 0.36%, Pretax Profit Margin comes in at 0.34%, and Net Profit Margin reading is 0.3%. To continue investigating profitability, this company’s Return on Assets is posted at 0.17, Equity is 0.39 and Total Capital is 0.28. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.8.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 106.19 points at the first support level, and at 105.60 for the second support level. However, for the 1st resistance point, the stock is sitting at 107.21, and for the 2nd resistance point, it is at 107.64.
Ratios To Look Out For
It is important to note that Merck & Co Inc [NYSE:MRK] has a current ratio of 1.66. On the other hand, the Quick Ratio is 1.44, and the Cash Ratio is 0.63. Considering the valuation of this stock, the price to sales ratio is 4.15, the price to book ratio is 5.12 and price to earnings (TTM) ratio is 14.13.
Transactions by insiders
Recent insider trading involved Downing Cristal N, Chief Comm. & Public Afrs Ofcr, that happened on Nov 10 ’25 when 7085.0 shares were sold. Officer, CRISTAL DOWNING completed a deal on Nov 10 ’25 to buy 7085.0 shares. Meanwhile, EVP,Chief Info&Digital Officer Williams David Michael sold 8614.0 shares on Nov 03 ’25.
